selenium has been researched along with Diabetic Nephropathies in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Karmalawy, AA; Antar, SA; El-Azab, MF; Hanna, PA; Hazem, RM; Tawfik, KM | 1 |
| Abdelghany, AM; Samra, YA; Zaghloul, RA | 1 |
| Cao, H; Huan, Y; Huang, K; Ji, W; Lei, L; Li, C; Liu, Q; Liu, S; Shen, Z; Sun, S; Wang, X; Zhou, J | 1 |
| Abdo, SA; Arisha, AH; Ebraheim, LLM; El-Mandrawy, SAM; Khater, SI; Mohamed, AA; Mohammed, AT; Nassan, MA | 1 |
| Al-Tamimi, J; Alhazza, IM; Ebaid, H; Habila, MA; Hassan, I; Omar, MS; Sheikh, M | 1 |
| Kaur, J; Khurana, A; Kulkarni, A; Kumar, GS; Tikoo, K | 1 |
| Asemi, Z; Bahmani, F; Esmaillzadeh, A; Kia, M; Soleimani, A | 1 |
| Asemi, Z; Bahmani, F; Kia, M; Mohammadi, AA; Soleimani, A | 1 |
| Garay-Sevilla, ME; Garcia-Ramirez, JR; Kornhauser, C; Pérez-Luque, EL; Wrobel, K | 1 |
| Kähler, W; Kuklinski, B; Plötz, C; Rühlmann, C | 1 |
| Accominotti, M; Borson-Chazot, F; Bost, M; Ciavatti, M; Douillet, C; Tabib, A | 1 |
3 trial(s) available for selenium and Diabetic Nephropathies
| Article | Year |
|---|---|
Effect of Selenium Supplementation on Glycemic Control and Lipid Profiles in Patients with Diabetic Nephropathy.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Supplements; Double-Blind Method; Female; Humans; Lipids; Male; Middle Aged; Selenium | 2016 |
The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Biomarkers; C-Reactive Protein; Diabetic Nephropathies; Dietary Supplements; Double-Blind Method; Female; Glutathione; Humans; Inflammation; Iran; Male; Malondialdehyde; Matrix Metalloproteinase 2; Middle Aged; Nitric Oxide; Oxidative Stress; Placebos; Prospective Studies; Selenium | 2016 |
[Diabetes mellitus--a free radical-associated disease. Results of adjuvant antioxidant supplementation].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Lipids; Male; Malondialdehyde; Middle Aged; Neurologic Examination; Oxygen; Selenium; Sodium Selenite; Thioctic Acid; Vitamin E | 1993 |
8 other study(ies) available for selenium and Diabetic Nephropathies
| Article | Year |
|---|---|
A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; HMGB1 Protein; Kidney; Molecular Docking Simulation; NF-kappa B; Oxidative Stress; Rats; Selenium; Sildenafil Citrate; Streptozocin | 2022 |
Rutin and selenium nanoparticles protected against STZ-induced diabetic nephropathy in rats through downregulating Jak-2/Stat3 pathway and upregulating Nrf-2/HO-1 pathway.
Topics: Animals; Biomarkers; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Interleukin-6; Nanoparticles; NF-kappa B; Rats; Rats, Sprague-Dawley; Rutin; Selenium; Signal Transduction; Sirtuins; STAT3 Transcription Factor; Streptozocin; Tumor Necrosis Factor-alpha | 2022 |
Diphenyl Diselenide Alleviates Tert-Butyl Hydrogen Peroxide-Induced Oxidative Stress and Lipopolysaccharide-Induced Inflammation in Rat Glomerular Mesangial Cells.
Topics: Animals; Anti-Inflammatory Agents; Benzene Derivatives; Diabetic Nephropathies; Hydrogen Peroxide; Hypoglycemic Agents; Inflammation; Interleukin-1beta; Kelch-Like ECH-Associated Protein 1; Lipopolysaccharides; Mesangial Cells; NF-E2-Related Factor 2; Organoselenium Compounds; Oxidative Stress; Rats; Reactive Oxygen Species; RNA, Messenger; Selenium; Superoxide Dismutase; tert-Butylhydroperoxide; Tumor Necrosis Factor-alpha | 2022 |
Stabilized-chitosan selenium nanoparticles efficiently reduce renal tissue injury and regulate the expression pattern of aldose reductase in the diabetic-nephropathy rat model.
Topics: Aldehyde Reductase; Animals; Chitosan; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Kidney; Kidney Function Tests; Male; Nanoparticles; Rats; Rats, Sprague-Dawley; Selenium | 2021 |
Supplementation with selenium nanoparticles alleviates diabetic nephropathy during pregnancy in the diabetic female rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Supplements; Female; Nanoparticles; Pregnancy; Rats; Selenium | 2022 |
Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Fibronectins; HSP70 Heat-Shock Proteins; Kidney; Male; Nanoparticles; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Selenium; Sirtuin 1 | 2014 |
Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients.
Topics: Adult; Albuminuria; Antioxidants; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glutathione Peroxidase; Humans; Male; Middle Aged; Selenium | 2008 |
A selenium supplement associated or not with vitamin E delays early renal lesions in experimental diabetes in rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Food, Fortified; Kidney Glomerulus; Male; Organ Size; Rats; Rats, Sprague-Dawley; Selenium; Streptozocin; Vitamin E | 1996 |